REQUEST A DEMO
Total
USD $0.00
Search more companies

Phoenix Pharma D.O.O. (Serbia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Phoenix Pharma D.O.O. Beograd Profile Updated: June 24, 2019
Buy our report for this company USD 29.95 Most recent financial data: 2017 Available in: English Download a sample report

Phoenix Pharma D.O.O. Beograd was established in 1991 under the Pharmanova Co. name. The company is primarily engaged in the wholesale distribution of medicines and pharmaceutical products of local and international manufacturers. It operates distribution centers in Belgrade, Novi Sad and Leskovac. Phoenix Pharma D.O.O. is member of the PHOENIX Balkan Group, which includes also Bosnian, Bulgarian and Macedonian units.

Headquarters
Bore Stankovica 2
Belgrade; Belgrade; Postal Code: 11030

Contact Details: Purchase the Phoenix Pharma D.O.O. report to view the information.

Website: http://www.pharmanova.com

Basic Information
Total Employees:
Purchase the Phoenix Pharma D.O.O. report to view the information.
Registered Capital:
Purchase the Phoenix Pharma D.O.O. report to view the information.
Financial Auditors:
Purchase the Phoenix Pharma D.O.O. report to view the information.
Incorporation Date:
November 04, 1990
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Representative
Purchase this report to view the information.
Representative
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Evropa Lek Pharma D.O.O.
100%
Ino-Pharm D.O.O.
100%
Company Performance
Financial values in the chart are available after Phoenix Pharma D.O.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RSD. Absolute financial data is included in the purchased report.
Net sales revenue
9.37%
Total operating revenue
9.4%
Operating profit (EBIT)
18.62%
EBITDA
23.54%
Net Profit (Loss) for the Period
375.05%
Total assets
4.53%
Total equity
-8.3%
Operating Profit Margin (ROS)
0.15%
Net Profit Margin
1.49%
Return on Equity (ROE)
12.42%
Debt to Equity Ratio
-0.12%
Quick Ratio
0.02%
Cash Ratio
0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?